For better or for worse: the role of Pim oncogenes in tumorigenesis
- 9 December 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Cancer
- Vol. 11 (1), 23-34
- https://doi.org/10.1038/nrc2986
Abstract
Pim oncogenes are overexpressed in a wide range of tumours from a haematological and epithelial origin. Pim genes encode serine/threonine kinases that have been shown to counteract the increased sensitivity to apoptosis induction that is associated with MYC-driven tumorigenesis. Recently, considerable progress has been made in characterizing the pathways of PIM-mediated survival signalling. Given the unique structure of their active site and the minimal phenotype of mice mutant for all Pim family members, these oncogenes might be promising targets for highly specific and selective drugs with favourable toxicity profiles. In this Review, we discuss the physiological functions and oncogenic activities of Pim kinases.Keywords
This publication has 140 references indexed in Scilit:
- c-Myc Regulates Transcriptional Pause ReleaseCell, 2010
- miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic BlastsCell, 2010
- Genetic Dissection of the Oncogenic mTOR Pathway Reveals Druggable Addiction to Translational Control via 4EBP-eIF4ECancer Cell, 2010
- Defining mechanisms that regulate RNA polymerase II transcription in vivoNature, 2009
- Control of Inducible Gene Expression by Signal-Dependent Transcriptional ElongationCell, 2009
- c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolismNature, 2009
- The great MYC escape in tumorigenesisCancer Cell, 2005
- Evasion of the p53 tumour surveillance network by tumour-derived MYC mutantsNature, 2005
- Delineation of prognostic biomarkers in prostate cancerNature, 2001
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000